Sort
30,917 grants matching “tumor microenvironment”
Systems Metabolic Approach for Multi-scale Pancreatic Cancer Phenotyping
$629,699Neema Jamshidi · University Of California Los Angeles · R37 · FY2025 · CA
Matrix Organization and Dimensionality
$629,690Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
$629,612Kwok Kin Wong · New York University School Of Medicine · U01 · FY2020 · CA
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$629,475Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Focal Adhesion Kinase inhibition for dual targeting of osteosarcoma cells and the tumor microenvironment to prevent metastasis
$629,341Daniel Patrick Regan · Colorado State University · R37 · FY2025 · CA
Genetically engineered mouse model to improve therapy of NUT carcinoma
$629,248Christopher A French · Brigham And Women'S Hospital · R01 · FY2024 · CA
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
$629,224Cesar M Castro · Massachusetts General Hospital · R01 · FY2024 · CA
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
$629,131Elizabeth Marjorie Cespedes Feliciano · Kaiser Foundation Research Institute · R01 · FY2023 · CA
Targeting Neoantigens in Triple Negative Breast Cancer
$629,038William E Gillanders · Washington University · R01 · FY2019 · CA
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers
$629,001Ricardo Otazo · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis
$628,972William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer
$628,901Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2017 · CA
MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1
$628,850Pawel Kalinski · Roswell Park Cancer Institute Corp · P50 · FY2015 · CA
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia
$628,845John Eisenbrey · Thomas Jefferson University · R01 · FY2021 · EB
Interdisciplinary Epidemiologic Consortium to Investigate T-cell Response in Colorectal Cancer
$628,814Ulrike Peters · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Dynamics in the Tissue State: From Normal to Tumor and Back
$628,639Jan T. Liphardt · University Of California Berkeley · U54 · FY2011 · CA
The Oncogene Activated Mitochondrial Unfolded Protein Response Regulates Senescence Biology
$628,593Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Innovative mRNA vaccines to enhance the efficacy of T-cell transfer therapies against solid tumors
$628,499Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2024 · CA
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
$628,483Shrikant Anant · University Of Kansas Medical Center · R01 · FY2016 · CA
Tumor and immune determinants of effective anti-tumor immunity in renal cell carcinoma
$628,445David Braun · Yale University · R37 · FY2024 · CA
Design and characterization of bacterial population dynamics in solid tumor models
$628,437Jeff M Hasty · University Of California, San Diego · R01 · FY2023 · EB
Design and characterization of bacterial population dynamics in solid tumor models
$628,437Jeff M Hasty · University Of California, San Diego · R01 · FY2022 · EB
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles
$628,431Yazhen Zhu · University Of California Los Angeles · R01 · FY2024 · CA
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$628,386Jin Wang · Baylor College Of Medicine · R01 · FY2025 · CA
Project 2: T Cell Costimulation: Induction and Regulation of Autoimmunity
$628,325Arlene H Sharpe · Harvard Medical School · P01 · FY2019 · AI